Asston Pharmaceuticals (BOM:544445) EPS (Basic): ₹4.92 (TTM As of Mar. 2026)


BOM:544445 Asston Pharmaceuticals Ltd BOM:544445
19 GF Score
Price ₹82.00
! 3 Warning Signs
View Full Analysis

What is Asston Pharmaceuticals EPS (Basic)?

Asston Pharmaceuticals BOM:544445 19 EPS (Basic) is ₹4.92 as of Mar. 2026. GuruFocus rates BOM:544445 with a GF Score™ of 19/100. The stock has 3 warning signs investors should review.

Asston Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹4.87. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.92.

Asston Pharmaceuticals's EPS (Diluted) for the six months ended in Mar. 2026 was ₹4.87. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.92.

Asston Pharmaceuticals's EPS without NRI for the six months ended in Mar. 2026 was ₹1.42. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 4.92.

During the past 12 months, Asston Pharmaceuticals's average EPS without NRIGrowth Rate was 8.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 58.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Asston Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 226.50% per year. The lowest was 58.30% per year. And the median was 142.40% per year.

Asston Pharmaceuticals  (BOM:544445) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Asston Pharmaceuticals EPS (Basic) Related Terms

Asston Pharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Asston Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asston Pharmaceuticals EPS (Basic) Chart

Asston Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
0.13 1.24 1.60 4.53 4.92

Asston Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial 0.00 2.23 2.85 0.05 4.87
BOM:544445
19GF Score
Asston Pharmaceuticals Ltd BOM:544445
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asston Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Asston Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(38.652-0)/7.856
=4.92

Asston Pharmaceuticals's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(38.312-0)/7.856
=4.88

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹4.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹4.92 mean?
Asston Pharmaceuticals (BOM:544445) has a EPS (Basic) of ₹4.92 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Asston Pharmaceuticals and its competitors.
Is Asston Pharmaceuticals' EPS (Basic) too high?
Asston Pharmaceuticals' current EPS (Basic) is ₹4.92. Overall, Asston Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Asston Pharmaceuticals' EPS (Basic) compare to ZTS?
Asston Pharmaceuticals' EPS (Basic) of ₹4.92 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Asston Pharmaceuticals and its competitors. Asston Pharmaceuticals's current EPS (Basic) is ₹4.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asston Pharmaceuticals stock overvalued right now?
Asston Pharmaceuticals (BOM:544445) has a current EPS (Basic) of ₹4.92. The current EPS (Basic) is ₹4.92. Asston Pharmaceuticals' overall GF Score™ is 19/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Asston Pharmaceuticals (BOM:544445), the current EPS (Basic) is ₹4.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Asston Pharmaceuticals Business Description

Address Plot No 42A, Sector-11, 4th Floor, Office No. A-431 Balaji Bhavan, CBD Belapur, Navi Mumbai, Thane, MH, IND, 400 614
Asston Pharmaceuticals Ltd manufactures and exports pharmaceutical and nutraceutical products. The company produces a wide range of healthcare items including tablets, capsules, syrups, sachets, ointments, creams, gels, and lotions. It serves markets in West and South Africa, with expansions planned into Asian countries. Asston conducts business through export sales, contract manufacturing and loan license arrangements via merchant exporters, and domestic sales within India. Revenue is generated through the sale of branded and generic pharmaceutical formulations along with nutraceutical products. The business operations are broadly categorized into: Domestic Formulations, Export Formulations, APIs and Intermediates, and Research and Development.
19GF Score

Get the complete analysis for BOM:544445

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹82.00
Price